Ausgabe 1/2016
Inhalt (24 Artikel)
Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer
Alberto Ocaña, Javier Pérez-Peña, Laura Díez-González, Verónica Sánchez-Corrales, Arnoud Templeton, Bostjan Seruga, Eitan Amir, Atanasio Pandiella
The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts
Mohammed A. Aleskandarany, Devika Agarwal, Ola H. Negm, Graham Ball, Ahmed Elmouna, Ibraheem Ashankyty, Edem Nuglozeh, Mohammad F. Fazaludeen, Maria Diez-Rodriguez, Christopher C. Nolan, Patrick J. Tighe, Andrew R. Green, Ian O. Ellis, Emad A. Rakha
Whole exome sequencing of rare aggressive breast cancer histologies
Maria Vittoria Dieci, Veronika Smutná, Véronique Scott, Guangliang Yin, Ran Xu, Philippe Vielh, Marie-Christine Mathieu, Cécile Vicier, Melanie Laporte, Francoise Drusch, Valentina Guarneri, Pierfranco Conte, Suzette Delaloge, Ludovic Lacroix, Olivia Fromigué, Fabrice André, Celine Lefebvre
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin
Sanja B. Turturro, Matthew S. Najor, Carl E. Ruby, Melody A. Cobleigh, Abde M. Abukhdeir
Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas
Mayu Takagi, Yasuhiro Miki, Minoru Miyashita, Shuko Hata, Tomomi Yoda, Hisashi Hirakawa, Yasuaki Sagara, Yoshiaki Rai, Yasuyo Ohi, Kentaro Tamaki, Takanori Ishida, Takashi Suzuki, Noriaki Ouchi, Hironobu Sasano
Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells
Indira Pandiri, Yingqing Chen, Yeonsoo Joe, Hyo Jeong Kim, Jeongmin Park, Hun Taeg Chung, Jeong Woo Park
MSCs and inflammation: new insights into the potential association between ALCL and breast implants
M. Orciani, G. Sorgentoni, M. Torresetti, Roberto Di Primio, G. Di Benedetto
A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer
Dimitrios Dionyssiou, Efterpi Demiri, Antonis Tsimponis, Alexandros Sarafis, Vasillios Mpalaris, Georgia Tatsidou, Georgios Arsos
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
Miguel Martin, Jan C. Brase, Amparo Ruiz, Aleix Prat, Ralf Kronenwett, Lourdes Calvo, Christoph Petry, Philip S. Bernard, Manuel Ruiz-Borrego, Karsten E. Weber, César A. Rodriguez, Isabel M. Alvarez, Miguel A. Segui, Charles M. Perou, Maribel Casas, Eva Carrasco, Rosalía Caballero, Alvaro Rodriguez-Lescure
Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score
Andreas D. Hartkopf, Markus Wallwiener, Stefan Kommoss, Florin-Andrei Taran, Sara Y. Brucker
Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial
A. Welt, N. Marschner, C. Lerchenmueller, T. Decker, C.-C. Steffens, A. Koehler, R. Depenbusch, S. Busies, S. Hegewisch-Becker
Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium
Emily F. Conant, Elisabeth F. Beaber, Brian L. Sprague, Sally D. Herschorn, Donald L. Weaver, Tracy Onega, Anna N. A. Tosteson, Anne Marie McCarthy, Steven P. Poplack, Jennifer S. Haas, Katrina Armstrong, Mitchell D. Schnall, William E. Barlow
A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer
T. Zhu, C. L. Liu, Y. F. Zhang, Y. H. Liu, F. P. Xu, J. Zu, G. C. Zhang, X. R. Li, N. Liao, K. Wang
Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study
Minish M. Jain, Smita U. Gupte, Shekhar G. Patil, Anand B. Pathak, Chetan D. Deshmukh, Niraj Bhatt, Chiramana Haritha, K. Govind Babu, Shailesh A. Bondarde, Raghunadharao Digumarti, Jyoti Bajpai, Ravi Kumar, Ashish V. Bakshi, Gouri Sankar Bhattacharya, Poonam Patil, Sundaram Subramanian, Ashok K. Vaid, Chirag J. Desai, Ajay Khopade, Geetanjali Chimote, Poonamalle P. Bapsy, Shravanti Bhowmik
Lin28A and androgen receptor expression in ER−/Her2+ breast cancer
Honghong Shen, Yong Yang, Lin Zhao, Jinyang Yuan, Yun Niu
Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis
Jieqiong Liu, Huishan Guo, Kai Mao, Kan Zhang, Heran Deng, Qiang Liu
Childhood body mass index and adult mammographic density measures that predict breast cancer risk
John L. Hopper, Tuong L. Nguyen, Jennifer Stone, Kelly Aujard, Melanie C. Matheson, Michael J. Abramson, John A. Burgess, E. Haydn Walters, Gillian S. Dite, Minh Bui, Christopher Evans, Enes Makalic, Daniel F. Schmidt, Gail Ward, Mark A. Jenkins, Graham G. Giles, Shyamali C. Dharmage, Carmel Apicella
iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management
Ian M. Collins, Adrian Bickerstaffe, Thilina Ranaweera, Sanjaya Maddumarachchi, Louise Keogh, Jon Emery, G. Bruce Mann, Phyllis Butow, Prue Weideman, Emma Steel, Alison Trainer, Mathias Bressel, John L. Hopper, Jack Cuzick, Antonis C. Antoniou, Kelly-Anne Phillips
DNA methylation modifies the association between obesity and survival after breast cancer diagnosis
Lauren E. McCullough, Jia Chen, Yoon Hee Cho, Nikhil K. Khankari, Patrick T. Bradshaw, Alexandra J. White, Gail Garbowski, Susan L. Teitelbaum, Mary Beth Terry, Alfred I. Neugut, Hanina Hibshoosh, Regina M. Santella, Marilie D. Gammon
Study of breast cancer incidence in patients of lymphangioleiomyomatosis
Olivier Nuñez, Antonio Román, Simon R. Johnson, Yoshikazu Inoue, Masaki Hirose, Álvaro Casanova, Gorka Ruiz de Garibay, Carmen Herranz, Gema Bueno-Moreno, Jacopo Boni, Francesca Mateo, Anna Petit, Fina Climent, Teresa Soler, August Vidal, José Vicente Sánchez-Mut, Manel Esteller, José Ignacio López, Nadia García, Anna Gumà, Raúl Ortega, María Jesús Plà, Miriam Campos, Emilio Ansótegui, María Molina-Molina, Claudia Valenzuela, Piedad Ussetti, Rosalía Laporta, Julio Ancochea, Antoni Xaubet, Marina Pollán, Miguel Angel Pujana
Comments on ‘Brief screening of patients with distressing fear of recurrence in breast cancer survivors’ by Akechi et al., Breast Cancer Res Treat, 2015, 153(2): pp. 475–476
B. Thewes, M. van de Wal, J. Prins
Author reply: Brief screening of breast cancer survivors with distressing fear of recurrence
Tatsuo Akechi, Kanae Momino, Hiroji Iwata
Erratum to: JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3
Liliang Li, Pan Gao, Yuhua Li, Yiwen Shen, Jianhui Xie, Daming Sun, Aimin Xue, Ziqin Zhao, Zude Xu, Mingchang Zhang, Beixu Li, Jieqing Jiang
Erratum to: Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo
Elke Ziegler, Marie-Therese Hansen, Maike Haase, Günter Emons, Carsten Gründker